Skip to content

Corporate brand

Unclaimed

A nonprofit educational organization and online library documenting psychoactive plants, chemicals, experiences, research, and harm-reduction information.

Last updated October 14, 2026

AI crawler reads

No AI crawler has read this profile yet.

Overview

Erowid is a nonprofit educational organization best known for Erowid.org, an extensively used online library about psychoactive plants, chemicals, technologies, and related social, health, legal, cultural, and spiritual issues. Its coverage includes both legal and prohibited substances and is designed to present information in a comparatively objective and non-judgmental format. The site combines published scientific and medical literature, expert contributions, historical and cultural documents, media reports, chemical and pharmacological information, and personal accounts submitted by members of the public. The project began in April 1995 as a small business created by the individuals known publicly as Fire Erowid and Earth Erowid. The website went online approximately six months later. The name Erowid was selected to express the project's educational philosophy and is described as deriving from Proto-Indo-European roots associated roughly with “earth” and “wisdom.” In 2005, the work was formalized through Erowid Center, a United States 501(c)(3) nonprofit educational organization. The center is donation-supported, and Erowid.org operates without conventional advertising. Erowid's central service is its online reference library. It contains substance profiles, research summaries and abstracts, frequently asked questions, information on chemistry, dosage, effects, health, law, testing, traditional and spiritual use, and selected images and media. Its Experience Vaults provide a large, edited collection of first-person reports describing positive, negative, neutral, unexpected, and otherwise significant experiences with psychoactive substances. Erowid states that submitted accounts are reviewed before publication; the collection includes tens of thousands of published reports, with additional submissions awaiting review. The organization has also collaborated with Bluelight.org in collecting, categorizing, and publishing experience reports. Erowid's work extends beyond publishing. It has supplied research, data, archival material, and subject-matter expertise to harm-reduction, health, educational, scientific, and psychedelic-research organizations. It has worked with the Multidisciplinary Association for Psychedelic Studies on online psychoactive-drug reference resources and has maintained archives involving figures and collections connected with psychedelic science, including Albert Hofmann, Myron Stolaroff, Alexander Shulgin, and the former Hive website. Erowid also publishes Erowid Extracts, a biannual members' newsletter covering organizational developments, survey results, experience reports, new articles, and psychedelic culture. A major associated project is DrugsData, formerly known as EcstasyData. Launched in July 2001 with IsomerDesign and DanceSafe, the laboratory drug-checking program originally focused on anonymously submitted ecstasy tablets. It later broadened its scope to other recreational drugs and published laboratory findings showing what a sample contained as well as what it was represented to be. The project reported results for more than 20,000 samples over roughly 23 years, but its service entered an administrative pause on April 10, 2024, following an order from the United States Drug Enforcement Administration. Erowid occupies a distinctive position between a public reference archive, a harm-reduction resource, and a publisher of community-generated evidence. Supporters value its breadth, accessibility, and willingness to document adverse as well as desirable effects. Critics, including some medical and toxicology professionals, have questioned whether detailed drug information could encourage use or create misleading confidence. Academic observers have also described the site's experience reports and drug-testing data as potentially useful forms of post-market surveillance for illicit or experimental substances. Erowid remains primarily an information and archival project rather than a seller of psychoactive products.

History

Erowid originated in April 1995 when Fire Erowid and Earth Erowid established a small project devoted to collecting and sharing information about psychoactive substances and related subjects. Its website was published about six months later. The name was chosen to reflect an educational ideal described through Proto-Indo-European linguistic roots, with an approximate meaning connected to earth and wisdom. During its early development, Erowid grew from a small web project into a substantial public reference archive. Its editorial approach combined scientific and medical publications with historical texts, expert contributions, media coverage, images, and firsthand accounts. Rather than limiting its scope to officially recognized medicines or legal substances, the project documented a broad range of psychoactive plants and chemicals, including substances whose manufacture, possession, or distribution may be prohibited in particular jurisdictions. The resulting library addressed effects, adverse reactions, dosage, chemistry, health, law, traditional use, spiritual contexts, and research. In 2005, Erowid Center was established as a United States 501(c)(3) nonprofit educational organization. The center became the formal institutional home for Erowid's activities and is supported by donations. Its website remains free of advertising. The organization is based in Northern California, while its resources are used internationally by members of the public, researchers, journalists, authors, filmmakers, medical and health professionals, and educational organizations. A major part of the site's development was the creation of the Experience Vaults. Visitors can submit accounts of their experiences with psychoactive substances, and Erowid reviews selected submissions before publication. The collection is intended to include favorable, unfavorable, mixed, neutral, and otherwise informative accounts rather than presenting only one view of drug use. Erowid has also worked with Bluelight.org to organize and publish experience reports. These accounts became one of the site's most distinctive forms of community-generated evidence. Erowid expanded its work through partnerships, research support, and archival preservation. Together with the Multidisciplinary Association for Psychedelic Studies, it contributed expertise to online psychoactive-drug reference resources. It also preserved and made available older materials connected with psychedelic science and culture, including the Albert Hofmann collection, the Myron Stolaroff Collection, documents associated with Alexander Shulgin, and an archived version of the Hive website. These activities reflected Erowid's interest in documenting not only pharmacology but also the changing historical and cultural contexts of psychoactive-substance use. In July 2001, Erowid, IsomerDesign, and DanceSafe launched EcstasyData, an anonymous laboratory drug-checking initiative. The project collected ecstasy tablets for analysis and published photographs and gas chromatography/mass spectrometry results. Over time, its remit expanded beyond ecstasy, and the service was renamed DrugsData. Published records identified the chemical composition of submitted samples and compared those findings with how the samples had been marketed or represented. The database became a source for researchers studying illicit drug markets and adulteration. On April 10, 2024, DrugsData reported an administrative pause following an order from the DEA. Since 2001, Erowid has also published Erowid Extracts, a biannual members' newsletter containing organizational updates, survey findings, experience reports, articles, and coverage of psychedelic culture and events. The organization continues to operate chiefly as a publisher, archive, and educational resource. Its work has attracted both praise and criticism: supporters describe it as unusually comprehensive and candid, while some clinicians and toxicologists have raised concerns that detailed information might facilitate drug use or be misunderstood. Academic commentary has additionally treated Erowid's experience reports and drug-testing records as potentially valuable forms of post-market surveillance for illicit and experimental substances.

  • 2024

    DrugsData pauses operations

    [1]

    The drug-checking service enters an administrative pause on April 10 following an order from the DEA.

  • 2005

    Erowid Center is formed

    [1]

    The nonprofit Erowid Center is established as a United States 501(c)(3) educational organization.

  • 2001

    Erowid Extracts begins publication

    [1]

    Erowid begins publishing its biannual members' newsletter, which continues to cover research, reports, surveys, and psychedelic culture.

  • 2001

    EcstasyData launches

    [1]

    Erowid, IsomerDesign, and DanceSafe launch an anonymous laboratory-testing project for ecstasy tablets.

  • 1995

    Erowid is founded

    [1]

    Fire Erowid and Earth Erowid establish the Erowid project in April as a small business focused on psychoactive-substance information.

  • 1995

    Erowid website launches

    [1]

    The project's website is published approximately six months after the organization is founded.

Products and positioning

An independent, donation-supported, noncommercial information and harm-reduction resource that documents psychoactive substances through scientific literature, expert material, historical archives, laboratory data, and reviewed personal accounts.

  • Digital reference library · 1995

    Erowid.org Online Library

    Erowid's core public resource is a large online library covering psychoactive plants, chemicals, technologies, and related issues. Its materials include substance profiles, research summaries, abstracts, frequently asked questions, chemistry and dosage information, effects and adverse effects, health and legal material, traditional and spiritual contexts, images, and archived documents. The library draws on published literature, experts, media, and community contributions and is available without conventional advertising.

  • User-submitted experience archive

    Experience Vaults

    The Experience Vaults contain reviewed and edited first-person accounts of psychoactive-substance experiences. Erowid accepts accounts reflecting positive, negative, neutral, mixed, and unexpected outcomes, making the collection broader than a promotional account of drug effects. The archive is used by readers seeking experiential context alongside formal research, while its editorial process determines which submissions are published.

  • Drug-checking data service · 2001

    DrugsData

    DrugsData, formerly EcstasyData, is an independent laboratory drug-checking program associated with Erowid, IsomerDesign, and DanceSafe. It accepts anonymously submitted samples through licensed laboratory arrangements and publishes photographs and analytical results, including the difference between a sample's marketed identity and its detected chemical composition. The service reported results for more than 20,000 samples before entering an administrative pause in 2024.

  • Newsletter · 2001

    Erowid Extracts

    Erowid Extracts is a biannual members' newsletter. It reports on Erowid's activities, surveys conducted through the site, experience reports, new writing about psychoactive plants and drugs, and developments in psychedelic culture and events. Current issues are distributed to members, while earlier issues are made available through the Erowid website.

Brand decisions

  • 2024

    Administrative pause for DrugsDataOther

    Background

    DrugsData had operated for more than two decades as an associated laboratory drug-checking and public-results project.

    Action taken

    The service paused operations on April 10, 2024, following an order from the United States Drug Enforcement Administration.

    Aftermath

    The project stopped accepting or processing services during the pause; its previously published testing records remained an important part of its public data legacy.

Sources2 sources

Cite this profile: Cite the canonical profile. /brand-wiki/erowid · Editorial policy · How profiles are compiled